S&P 500   3,386.15 (+0.47%)
DOW   29,348.03 (+0.40%)
QQQ   236.98 (+0.96%)
AAPL   323.62 (+1.45%)
MSFT   187.28 (+0.03%)
AMZN   2,170.22 (+0.67%)
CGC   21.77 (-0.77%)
NVDA   314.70 (+6.11%)
BABA   222.14 (+0.73%)
MU   59.99 (+3.88%)
GE   12.61 (-1.10%)
TSLA   917.42 (+6.88%)
T   38.44 (+0.47%)
ACB   1.71 (+4.27%)
F   8.00 (-0.74%)
NFLX   386.19 (-0.41%)
PRI   135.69 (+0.05%)
BAC   34.72 (+1.31%)
DIS   141.30 (+1.55%)
GILD   67.35 (+0.51%)
S&P 500   3,386.15 (+0.47%)
DOW   29,348.03 (+0.40%)
QQQ   236.98 (+0.96%)
AAPL   323.62 (+1.45%)
MSFT   187.28 (+0.03%)
AMZN   2,170.22 (+0.67%)
CGC   21.77 (-0.77%)
NVDA   314.70 (+6.11%)
BABA   222.14 (+0.73%)
MU   59.99 (+3.88%)
GE   12.61 (-1.10%)
TSLA   917.42 (+6.88%)
T   38.44 (+0.47%)
ACB   1.71 (+4.27%)
F   8.00 (-0.74%)
NFLX   386.19 (-0.41%)
PRI   135.69 (+0.05%)
BAC   34.72 (+1.31%)
DIS   141.30 (+1.55%)
GILD   67.35 (+0.51%)
S&P 500   3,386.15 (+0.47%)
DOW   29,348.03 (+0.40%)
QQQ   236.98 (+0.96%)
AAPL   323.62 (+1.45%)
MSFT   187.28 (+0.03%)
AMZN   2,170.22 (+0.67%)
CGC   21.77 (-0.77%)
NVDA   314.70 (+6.11%)
BABA   222.14 (+0.73%)
MU   59.99 (+3.88%)
GE   12.61 (-1.10%)
TSLA   917.42 (+6.88%)
T   38.44 (+0.47%)
ACB   1.71 (+4.27%)
F   8.00 (-0.74%)
NFLX   386.19 (-0.41%)
PRI   135.69 (+0.05%)
BAC   34.72 (+1.31%)
DIS   141.30 (+1.55%)
GILD   67.35 (+0.51%)
S&P 500   3,386.15 (+0.47%)
DOW   29,348.03 (+0.40%)
QQQ   236.98 (+0.96%)
AAPL   323.62 (+1.45%)
MSFT   187.28 (+0.03%)
AMZN   2,170.22 (+0.67%)
CGC   21.77 (-0.77%)
NVDA   314.70 (+6.11%)
BABA   222.14 (+0.73%)
MU   59.99 (+3.88%)
GE   12.61 (-1.10%)
TSLA   917.42 (+6.88%)
T   38.44 (+0.47%)
ACB   1.71 (+4.27%)
F   8.00 (-0.74%)
NFLX   386.19 (-0.41%)
PRI   135.69 (+0.05%)
BAC   34.72 (+1.31%)
DIS   141.30 (+1.55%)
GILD   67.35 (+0.51%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Viveve MedicalReShape LifesciencesEscalon MedicalReshape LifesciencesTrimedyne
SymbolNASDAQ:VIVEOTCMKTS:RSLSDOTCMKTS:ESMCOTCMKTS:RSLSOTCMKTS:TMED
Price Information
Current Price$1.80$5.55$0.20$7.85$4.80
52 Week RangeHoldN/AN/AN/AN/A
Analyst Ratings
Consensus RecommendationHoldN/AN/AN/AN/A
Consensus Price Target$0.60N/AN/AN/AN/A
% Upside from Price Target-66.67% downsideN/AN/AN/AN/A
Trade Information
Market Cap$1.74 million$1.94 million$1.51 million$2.66 million$590,000.00
Beta0.312.03-0.372.06-1.18
Average Volume2,694,2842,1803,0622,30445
Sales & Book Value
Annual Revenue$18.52 million$610,000.00$9.63 million$610,000.00$5.57 million
Price / Sales0.143.18N/A4.560.10
CashflowN/A$69.38 per shareN/A$71.36 per shareN/A
Price / CashN/A0.08N/A0.11N/A
Book Value$10.60 per share$341.84 per share$0.20 per share$341.84 per shareN/A
Price / Book0.170.02N/A0.02
Profitability
Net Income$-49,320,000.00$-81,150,000.00$-250,000.00$-81,150,000.00$230,000.00
EPS($161.00)N/AN/AN/AN/A
Trailing P/E RatioN/A0.0010.000.004.95
Forward P/E RatioN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-429.71%-668.58%4.19%-668.58%N/A
Return on Equity (ROE)N/A-163.22%24.25%-163.22%N/A
Return on Assets (ROA)-123.23%-52.10%7.50%-52.10%N/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.05%0.39%0.05%N/A
Current Ratio3.05%1.17%1.71%1.17%N/A
Quick Ratio2.39%1.07%0.93%1.07%N/A
Ownership Information
Institutional Ownership Percentage34.52%N/AN/A0.02%N/A
Insider Ownership Percentage5.20%N/A1.90%N/A11.10%
Miscellaneous
Employees674343N/AN/A
Shares Outstanding1.48 million350,000N/A354,000120,000
Next Earnings Date3/12/2020 (Estimated)5/21/2020 (Estimated)2/20/2020 (Estimated)5/21/2020 (Estimated)2/24/2020 (Estimated)
OptionableOptionableNot OptionableNot OptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel